Bevacizumab
ORB1219995
CAS Number216974-75-3
Product group Chemicals
Estimated Purity>98%
Molecular Weight149 kDa
Overview
- SupplierBiorbyt
- Product NameBevacizumab [216974-75-3]
- Delivery Days Customer10
- CAS Number216974-75-3
- CertificationResearch Use Only
- Estimated Purity>98%
- Molecular Weight149 kDa
- Scientific DescriptionIpilimumab anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint inhibitor.Bevacizumab a humanized monoclonal antibody specifically binds to all VEGF-A isoforms with high affinity.
- Storage Instruction-20°C
- UNSPSC12352200